The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trialYajing Zhu, Theodoros Foukakis, Ellinor Elinder et al.|Breast Cancer Research and Treatment|2024Cited by 6